Clinical Trials Browser

Phase 1 × sipuleucel-T × 90 days × Clear all

NCT05806814 2026-05-27

OU-SCC-EXCITE

Phase 1 Active not recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT07219147 2026-04-20

177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms